Optimized injection formulation for RNA

Details for Australian Patent Application No. 2006249093 (hide)

Owner Curevac GmbH

Inventors Pascolo, Steve; Hoerr, Ingmar

Agent Davies Collison Cave

Pub. Number AU-A-2006249093

PCT Pub. Number WO2006/122828

Priority 10 2005 023 170.5 19.05.05 DE

Filing date 19 May 2006

Wipo publication date 23 November 2006

International Classifications

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/122828 Priority application(s): WO2006/122828

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249100-Colonic delivery of adsorbents

2006249090-Single domain VHH antibodies against von Willebrand Factor